Andrew Bate
Andrew Bate
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
A Bayesian neural network method for adverse drug reaction signal generation
A Bate, M Lindquist, IR Edwards, S Olsson, R Orre, A Lansner, ...
European journal of clinical pharmacology 54 (4), 315-321, 1998
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
EP van Puijenbroek, A Bate, HGM Leufkens, M Lindquist, R Orre, ...
Pharmacoepidemiology and drug safety 11 (1), 3-10, 2002
Quantitative signal detection using spontaneous ADR reporting
A Bate, SJW Evans
Pharmacoepidemiology and drug safety 18 (6), 427-436, 2009
Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis
EJ Sanz, C De-las-Cuevas, A Kiuru, A Bate, R Edwards
The Lancet 365 (9458), 482-487, 2005
Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study
DM Coulter, A Bate, RHB Meyboom, M Lindquist, IR Edwards
Bmj 322 (7296), 1207-1209, 2001
A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database
M Lindquist, M Stĺhl, A Bate, IR Edwards, RHB Meyboom
Drug safety 23 (6), 533-542, 2000
Temporal pattern discovery in longitudinal electronic patient records
GN Norén, J Hopstadius, A Bate, K Star, IR Edwards
Data Mining and Knowledge Discovery 20 (3), 361-387, 2010
A data mining approach for signal detection and analysis
A Bate, M Lindquist, IR Edwards, R Orre
Drug safety 25 (6), 393-397, 2002
Myocarditis related to clozapine treatment
S Hägg, O Spigset, AB BAHons, TG Söderström
Journal of clinical psychopharmacology 21 (4), 382, 2001
Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events
GN Norén, A Bate, R Orre, IR Edwards
Statistics in medicine 25 (21), 3740-3757, 2006
Decision support methods for the detection of adverse events in post-marketing data
M Hauben, A Bate
Drug discovery today 14 (7-8), 343-357, 2009
Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1. 0
IISTFRWEHCDM S. V. Wang, S. Schneeweiss
Pharmacoepidemiology and Drug Safety 26 (9), 1018-1032, 2017
Bayesian neural networks with confidence estimations applied to data mining
R Orre, A Lansner, A Bate, M Lindquist
Computational Statistics & Data Analysis 34 (4), 473-493, 2000
A statistical methodology for drug–drug interaction surveillance
GN Norén, R Sundberg, A Bate, IR Edwards
Statistics in medicine 27 (16), 3057-3070, 2008
Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery
GN Norén, J Hopstadius, A Bate
Statistical methods in medical research 22 (1), 57-69, 2013
From association to alert—a revised approach to international signal analysis
M Lindquist, IR Edwards, A Bate, H Fucik, AM Nunes, M Stĺhl
Pharmacoepidemiology and drug safety 8 (S1), S15-S25, 1999
Disproportionality methods for pharmacovigilance in longitudinal observational databases
I Zorych, D Madigan, P Ryan, A Bate
Statistical methods in medical research 22 (1), 39-56, 2013
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU …
C Huerta, V Abbing‐Karahagopian, G Requena, B Oliva, Y Alvarez, ...
Pharmacoepidemiology and drug safety 25, 56-65, 2016
Duplicate detection in adverse drug reaction surveillance
GN Norén, R Orre, A Bate, IR Edwards
Data Mining and Knowledge Discovery 14 (3), 305-328, 2007
The application of knowledge discovery in databases to post‐marketing drug safety: example of the WHO database
A Bate, M Lindquist, IR Edwards
Fundamental & clinical pharmacology 22 (2), 127-140, 2008
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20